We did not find a significant IDH1 mutation prevalence in our cystic GBM cohort (Table 1) and observed survival differences amongst known IDH1 wild type cystic and noncystic GBM (Figure 5 and Supplement 5). The gene discussed is IDH1; the disease is glioblastoma.